MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest

MDxHealth SA (NASDAQ:MDXH) saw a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 38,900 shares, an increase of 140.1% from the November 15th total of 16,200 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average trading volume of 141,500 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Investors Weigh In On MDxHealth

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Maven Securities LTD bought a new stake in shares of MDxHealth during the third quarter valued at approximately $208,000. OneDigital Investment Advisors LLC lifted its holdings in MDxHealth by 15.3% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 57,726 shares of the company’s stock worth $120,000 after buying an additional 7,656 shares in the last quarter. MVM Partners LLC boosted its position in MDxHealth by 3.3% in the 3rd quarter. MVM Partners LLC now owns 4,700,457 shares of the company’s stock valued at $9,706,000 after buying an additional 150,000 shares during the last quarter. Finally, Perkins Capital Management Inc. boosted its position in MDxHealth by 70.7% in the 3rd quarter. Perkins Capital Management Inc. now owns 747,375 shares of the company’s stock valued at $1,555,000 after buying an additional 309,500 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Lake Street Capital assumed coverage on shares of MDxHealth in a report on Thursday, October 31st. They issued a “buy” rating and a $7.00 target price on the stock. Piper Sandler decreased their price objective on shares of MDxHealth from $8.00 to $6.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th.

MDxHealth Price Performance

Shares of NASDAQ:MDXH traded up $0.04 during midday trading on Friday, reaching $2.40. The company’s stock had a trading volume of 25,751 shares, compared to its average volume of 77,338. The business’s fifty day simple moving average is $1.99 and its 200-day simple moving average is $2.44. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45. MDxHealth has a fifty-two week low of $1.55 and a fifty-two week high of $4.64. The company has a market capitalization of $3.74 million, a P/E ratio of -1.58 and a beta of 1.42.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.